1. HER-2/neu oncogene protein and prognosis in breast cancer. J';Tandon, A.K.; Clark, G.M.; Chamness, G.C.; Ullrich, A.; McGuire, W.L.;Clin Oncol,1989
2. Association between high concentrations of M, 52 000 Cathepsin D and poor prognosis in primary human breast cancer;Thorpe, S.M.; Rochefort, H.; Garcia, M.; Freiss, G.; Christensen, I.G.J.; Khalaf, S.;Cancer Res,1989
3. Technetium-99m HMPAO and SPECT in the assessment of blood flow in human lung tumours;Rowell, N.P.; McCready, V.R.; Tait, D.; Flower, M.A.; Cronin, B.; Horwich, A.;BrJ Cancer,1989
4. In s-ivo 4P magnetic resonance spectroscopy for monitoring treatment response in breast cancer;Glaholm, J.; Leach, M.O.; Collins, D.J.; Mansi, G.; Sharp, J.C.; Madden, A.;Lancet,1989
5. The applications of positron emission tomography to oncology;Ott, R.J.;Br3rCancer,1991